EBIT at other companies
Other financials
Where this comes from
Calculated from Solid Biosciences Inc.’s reported figures.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s EBIT?
- Solid Biosciences Inc. (SLDB) reported EBIT of -$57.31M in Q1 2026.
- How has Solid Biosciences Inc.'s EBIT changed year-over-year?
- Solid Biosciences Inc.'s EBIT decreased by 43.1% year-over-year, from -$40.05M to -$57.31M.
- What is the long-term trend for Solid Biosciences Inc.'s EBIT?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s EBIT has grown at a 25.5% compound annual growth rate (CAGR), from -$72.25M to -$179.21M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.